In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
As of 12:01:44 pm GMT-4. Market open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results